Epidemiology of Nontuberculous Mycobacterial Infection, South Korea, 2007-2016

Overview

Journal Emerg Infect Dis

Specialty Infectious Diseases

Date 2019 Feb 22

PMID 30789139

Citations 75

Authors

Hyewon Lee

Woojae Myung

Won-Jung Koh

Seong Mi Moon

Byung Woo Jhun

Affiliations

Soon will be listed here.

Abstract

The prevalence and incidence of nontuberculous mycobacterial (NTM) infections increased in South Korea from 2007 to 2016. Annual prevalence of NTM infection increased to 39.6 cases/100,000 population in 2016 and annual incidence to 19.0 cases/100,000 population. Overall prevalence for the study period was higher in the elderly, in females, and in cities.

Citing Articles

: Three-year Mortality Following Prescription of Multidrug Antibiotic Treatment for Pulmonary Disease in United States Medicare Beneficiaries With Bronchiectasis.

Varley C, Ku J, Henkle E, Strnad L, Winthrop K Open Forum Infect Dis. 2024; 11(11):ofae639.

PMID: 39582505 PMC: 11584409. DOI: 10.1093/ofid/ofae639.

The effect of smoking on nontuberculous mycobacterial pulmonary disease and tuberculosis: a nationwide retrospective cohort study.

Chung C, Lee K, Han K, Shin D, Lee S Sci Rep. 2024; 14(1):22653.

PMID: 39349592 PMC: 11442629. DOI: 10.1038/s41598-024-72438-4.

Bronchiectasis in Asia: a review of current status and challenges.

Choi H, Xu J, Chotirmall S, Chalmers J, Morgan L, Dhar R Eur Respir Rev. 2024; 33(173).

PMID: 39322263 PMC: 11423131. DOI: 10.1183/16000617.0096-2024.

Medical Costs of Nontuberculous Mycobacterial Pulmonary Disease, South Korea, 2015-2019.

Chang S, Kim S, Kang Y, Park M, Sohn H, Park Y Emerg Infect Dis. 2024; 30(9):1841-1849.

PMID: 39173659 PMC: 11346975. DOI: 10.3201/eid3009.231448.

Screening, epidemic trends and drug sensitivity analysis of nontuberculous mycobacteria in a local area of China.

Lin W, Yao C, Mei L, Wang D, Bao X, Liu S Am J Transl Res. 2024; 16(7):3298-3305.

PMID: 39114690 PMC: 11301460. DOI: 10.62347/MAJY5046.

References

Adjemian J, Frankland T, Daida Y, Honda J, Olivier K, Zelazny A . Epidemiology of Nontuberculous Mycobacterial Lung Disease and Tuberculosis, Hawaii, USA. Emerg Infect Dis. 2017; 23(3):439-447. PMC: 5382761. DOI: 10.3201/eid2303.161827. View

Olivier K, Weber D, Wallace Jr R, Faiz A, Lee J, Zhang Y . Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med. 2002; 167(6):828-34. DOI: 10.1164/rccm.200207-678OC. View

Adjemian J, Olivier K, Seitz A, Holland S, Prevots D . Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med. 2012; 185(8):881-6. PMC: 3360574. DOI: 10.1164/rccm.201111-2016OC. View

Yohannes A, Alexopoulos G . Depression and anxiety in patients with COPD. Eur Respir Rev. 2014; 23(133):345-9. PMC: 4523084. DOI: 10.1183/09059180.00007813. View

Mirsaeidi M, Machado R, Garcia J, Schraufnagel D . Nontuberculous mycobacterial disease mortality in the United States, 1999-2010: a population-based comparative study. PLoS One. 2014; 9(3):e91879. PMC: 3954860. DOI: 10.1371/journal.pone.0091879. View

Henkle E, Hedberg K, Schafer S, Novosad S, Winthrop K . Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012. Ann Am Thorac Soc. 2015; 12(5):642-7. PMC: 4418336. DOI: 10.1513/AnnalsATS.201412-559OC. View

Adjemian J, Olivier K, Seitz A, Falkinham 3rd J, Holland S, Prevots D . Spatial clusters of nontuberculous mycobacterial lung disease in the United States. Am J Respir Crit Care Med. 2012; 186(6):553-8. PMC: 3480533. DOI: 10.1164/rccm.201205-0913OC. View

Seong S, Kim Y, Khang Y, Park J, Kang H, Lee H . Data Resource Profile: The National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2016; 46(3):799-800. PMC: 5837262. DOI: 10.1093/ije/dyw253. View

Morimoto K, Iwai K, Uchimura K, Okumura M, Yoshiyama T, Yoshimori K . A steady increase in nontuberculous mycobacteriosis mortality and estimated prevalence in Japan. Ann Am Thorac Soc. 2013; 11(1):1-8. DOI: 10.1513/AnnalsATS.201303-067OC. View

10.

Prevots D, Marras T . Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review. Clin Chest Med. 2015; 36(1):13-34. PMC: 4332564. DOI: 10.1016/j.ccm.2014.10.002. View

11.

Namkoong H, Kurashima A, Morimoto K, Hoshino Y, Hasegawa N, Ato M . Epidemiology of Pulmonary Nontuberculous Mycobacterial Disease, Japan. Emerg Infect Dis. 2016; 22(6):1116-7. PMC: 4880076. DOI: 10.3201/eid2206.151086. View

12.

Ringshausen F, Wagner D, de Roux A, Diel R, Hohmann D, Hickstein L . Prevalence of Nontuberculous Mycobacterial Pulmonary Disease, Germany, 2009-2014. Emerg Infect Dis. 2016; 22(6):1102-5. PMC: 4880102. DOI: 10.3201/eid2206.151642. View

13.

Prevots D, Shaw P, Strickland D, Jackson L, Raebel M, Blosky M . Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med. 2010; 182(7):970-6. PMC: 2970866. DOI: 10.1164/rccm.201002-0310OC. View

14.

Ko R, Moon S, Ahn S, Jhun B, Jeon K, Kwon O . Changing Epidemiology of Nontuberculous Mycobacterial Lung Diseases in a Tertiary Referral Hospital in Korea between 2001 and 2015. J Korean Med Sci. 2018; 33(8):e65. PMC: 5809754. DOI: 10.3346/jkms.2018.33.e65. View

15.

Winthrop K, Baxter R, Liu L, Varley C, Curtis J, Baddley J . Mycobacterial diseases and antitumour necrosis factor therapy in USA. Ann Rheum Dis. 2012; 72(1):37-42. DOI: 10.1136/annrheumdis-2011-200690. View